Search research articles
Contact Us
Filters
Showing results (41-50 of 141) with videos related to
Page
of 15
Sort By:
Acta Gastroenterologica Latinoamericana
|
October 25, 2007
[Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]
Fernando Van Domselaar, Daniel Correa, Carlos Vaccaro, et al.
Molecular Cancer
|
January 9, 2008
Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines
Faisal M Fadlelmola, Minglong Zhou, Ronald J de Leeuw, et al.
Academic Pathology
|
February 21, 2025
From good to great: The journey of sustained academic improvement of a university department of pathology and laboratory medicine
Zu-Hua Gao, Genevieve McMillan, Cheryl Wellington, et al.
Annals of Surgical Oncology
|
November 23, 2006
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment
Sam M Wiseman, Hamid Masoudi, Paddy Niblock, et al.
BMC Cancer
|
June 6, 2025
Risk-reducing salpingectomy: considerations from an OBGYN perspective
Alexandra Lukey, A Fuchsia Howard, Alice J Mei, et al.
Histopathology
|
November 7, 2013
A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary
Stefan Kommoss, Cyril Blake Gilks, Roland Penzel, et al.
The American Journal of Surgical Pathology
|
October 3, 2008
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary
Martin Köbel, Steve E Kalloger, Jon Carrick, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 14, 2002
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry
Forrest D Hsu, Torsten O Nielsen, Abdulmohsen Alkushi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome
Christopher B Moeder, Jennifer M Giltnane, Malini Harigopal, et al.
Breast Cancer Research : BCR
|
October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi, Samuel Leung, Jennifer H Law, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 141) with videos related to
Sort By:
Page
of 15
Acta Gastroenterologica Latinoamericana
|
October 25, 2007
[Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]
Fernando Van Domselaar, Daniel Correa, Carlos Vaccaro, et al.
Molecular Cancer
|
January 9, 2008
Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines
Faisal M Fadlelmola, Minglong Zhou, Ronald J de Leeuw, et al.
Academic Pathology
|
February 21, 2025
From good to great: The journey of sustained academic improvement of a university department of pathology and laboratory medicine
Zu-Hua Gao, Genevieve McMillan, Cheryl Wellington, et al.
Annals of Surgical Oncology
|
November 23, 2006
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment
Sam M Wiseman, Hamid Masoudi, Paddy Niblock, et al.
BMC Cancer
|
June 6, 2025
Risk-reducing salpingectomy: considerations from an OBGYN perspective
Alexandra Lukey, A Fuchsia Howard, Alice J Mei, et al.
Histopathology
|
November 7, 2013
A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary
Stefan Kommoss, Cyril Blake Gilks, Roland Penzel, et al.
The American Journal of Surgical Pathology
|
October 3, 2008
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary
Martin Köbel, Steve E Kalloger, Jon Carrick, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 14, 2002
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry
Forrest D Hsu, Torsten O Nielsen, Abdulmohsen Alkushi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome
Christopher B Moeder, Jennifer M Giltnane, Malini Harigopal, et al.
Breast Cancer Research : BCR
|
October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi, Samuel Leung, Jennifer H Law, et al.
Page
of 15